Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Fibrinolytic therapy].

J Beyer1, S Schellong

  • 1University Clinic "Carl Gustav Carus", Division of Vascular Medicine, Technical University Dresden, Fetscherstrasse 74, 01307 Dresden, Germany.

Hamostaseologie
|January 6, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of proinsulin C-peptide on nitric oxide, microvascular blood flow and erythrocyte Na+,K+-ATPase activity in diabetes mellitus type I.

Clinical science (London, England : 1979)·2000
Same author

[Comparison of hypoglycemia perception and hormonal counterregulation in controlled hypoglycemia. A contribution to diagnosis of hypoglycemia unawareness syndrome in type 1 diabetic patients].

Deutsche medizinische Wochenschrift (1946)·2000
Same author

[Predictive genetic investigations. Individualization of diagnosis and treatment in families with multiple endocrine neoplasia type II].

Deutsche medizinische Wochenschrift (1946)·2000
Same author

[Polyglandular autoimmune syndrome type II: epidemiology and forms of manifestation].

Deutsche medizinische Wochenschrift (1946)·2000
Same author

Pseudorabies virus expressing bovine herpesvirus 1 glycoprotein B exhibits altered neurotropism and increased neurovirulence.

Journal of virology·2000
Same author

Hematologic disorders associated with primary mediastinal nonseminomatous germ cell tumors.

Journal of the National Cancer Institute·2000
Same journal

Diagnosis and Management of Immune Platelet Transfusion Refractoriness.

Hamostaseologie·2026
Same journal

Too Common to Ignore: Decoding the Complexity of the FGG p.Ala108Gly Variant in Fibrinogen Disorders.

Hamostaseologie·2026
Same journal

Hamostaseologie·2026
Same journal

Hamostaseologie·2026
Same journal

Hamostaseologie·2026
Same journal

Hamostaseologie·2026
See all related articles

Fibrinolytic therapy is crucial for acute vascular occlusions but requires careful risk assessment. This review details common agents and provides evidence-based recommendations for its use in various vascular regions.

Area of Science:

  • Cardiovascular Medicine
  • Thrombosis and Hemostasis

Context:

  • Acute vascular occlusions necessitate timely and effective treatment strategies.
  • Fibrinolytic therapy remains a cornerstone treatment for occlusive vascular events.
  • Risk stratification is essential prior to initiating fibrinolytic therapy.

Purpose:

  • To review common fibrinolytic agents.
  • To present evidence and recommendations for fibrinolytic therapy across different vascular regions.
  • To guide clinicians in the safe and effective application of fibrinolysis.

Summary:

  • Fibrinolytic agents target and dissolve blood clots, restoring blood flow in acute occlusions.
  • The article discusses the mechanisms, indications, and contraindications of various fibrinolytic drugs.

Related Experiment Videos

  • Evidence-based guidelines are provided for optimizing fibrinolytic therapy in arterial and venous occlusions.

    • Impact:

    • Facilitates informed clinical decision-making regarding fibrinolytic therapy.
    • Aims to improve patient outcomes by ensuring appropriate risk assessment and treatment selection.
    • Contributes to the standardization of care for acute vascular occlusive diseases.